Filteren op Last updated date SelecterenNaVoorFrom - To Datum Einddatum Deze week Deze maand Afgelopen week Afgelopen maand Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationMedical devicesScientific adviceMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Laat dit veld leeg Filter Resultaten (3786) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Laat dit veld leeg Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 8-10 December 2020 11 december 2020 News Veterinary Medicines Vaccines Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 7-10 December 2020 Fifteen new medicines recommended for approval 11 december 2020 News Human Biosimilars Generic and hybrid medicines Medicines Cyberattack on the European Medicines Agency 9 december 2020 News Corporate Joint strategy sets direction for EMA and EU medicines regulatory agencies to 2025 8 december 2020 News Human EMA website briefly unavailable on 3 December 2020 2 december 2020 News Corporate EMA starts rolling review of Janssen’s COVID-19 vaccine Ad26.COV2.S 1 december 2020 News Human COVID-19 Vaccines EMA receives application for conditional marketing authorisation of Moderna COVID-19 vaccine 1 december 2020 News Human COVID-19 Vaccines EMA receives application for conditional marketing authorisation of COVID-19 mRNA vaccine BNT162b2 1 december 2020 News Human COVID-19 Vaccines Global regulators urge continuation of COVID-19 vaccine trials for longer-term safety and efficacy follow-up 27 november 2020 News Human COVID-19 Vaccines Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 23-26 November 2020 27 november 2020 News Human COVID-19 Pharmacovigilance Referrals 1 … 70 71 72 73 74 Page 74 of 379 75 76 77 78 … 379
Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 8-10 December 2020 11 december 2020 News Veterinary Medicines Vaccines
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 7-10 December 2020 Fifteen new medicines recommended for approval 11 december 2020 News Human Biosimilars Generic and hybrid medicines Medicines
Joint strategy sets direction for EMA and EU medicines regulatory agencies to 2025 8 december 2020 News Human
EMA starts rolling review of Janssen’s COVID-19 vaccine Ad26.COV2.S 1 december 2020 News Human COVID-19 Vaccines
EMA receives application for conditional marketing authorisation of Moderna COVID-19 vaccine 1 december 2020 News Human COVID-19 Vaccines
EMA receives application for conditional marketing authorisation of COVID-19 mRNA vaccine BNT162b2 1 december 2020 News Human COVID-19 Vaccines
Global regulators urge continuation of COVID-19 vaccine trials for longer-term safety and efficacy follow-up 27 november 2020 News Human COVID-19 Vaccines
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 23-26 November 2020 27 november 2020 News Human COVID-19 Pharmacovigilance Referrals